留言板

尊敬的读者、作者、审稿人, 关于本刊的投稿、审稿、编辑和出版的任何问题, 您可以本页添加留言。我们将尽快给您答复。谢谢您的支持!

姓名
邮箱
手机号码
标题
留言内容
验证码
x 关闭 永久关闭

应中央军委要求，2022年9月起，《药学实践杂志》将更名为《药学实践与服务》，双月刊，正文96页；2023年1月起，拟出版月刊，正文64页，数据库收录情况与原《药学实践杂志》相同。欢迎作者踊跃投稿！

细胞共培养模型在口服药物吸收研究中的应用

黎迎,  朱春燕

downloadPDF
文章导航 > 药学实践与服务  > 2015 >  33(4): 289-292,327
黎迎, 朱春燕. 细胞共培养模型在口服药物吸收研究中的应用[J]. 药学实践与服务, 2015, 33(4): 289-292,327. doi: 10.3969/j.issn.1006-0111.2015.04.001
引用本文: 黎迎, 朱春燕. 细胞共培养模型在口服药物吸收研究中的应用[J]. 药学实践与服务, 2015, 33(4): 289-292,327. doi: 10.3969/j.issn.1006-0111.2015.04.001
shu
LI Ying, ZHU Chunyan. Application of cell co-culture models in absorption of oral drug[J]. Journal of Pharmaceutical Practice and Service, 2015, 33(4): 289-292,327. doi: 10.3969/j.issn.1006-0111.2015.04.001
Citation: LI Ying, ZHU Chunyan. Application of cell co-culture models in absorption of oral drug[J]. Journal of Pharmaceutical Practice and Service, 2015, 33(4): 289-292,327. doi: 10.3969/j.issn.1006-0111.2015.04.001
shu

细胞共培养模型在口服药物吸收研究中的应用

doi: 10.3969/j.issn.1006-0111.2015.04.001

  • 中国医学科学院&北京协和医学院药用植物研究所, 北京 100193

基金项目: 国家自然科学基金面上项目(81274094);协和研究生创新基金项目(10023-1007-1017)

Application of cell co-culture models in absorption of oral drug

  • Institute of Medicinal Plant Development, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100193, China

  • 摘要: 细胞共培养体系能很好地模拟人体小肠生理环境,准确预测药物在肠道内的转运和代谢情况,增强体外细胞模型与整体动物实验研究之间的相关性,近年来在评价口服药物吸收方面发挥着越发重要的作用,已成为新药研发过程中评价药物口服吸收的热点。综述体外模拟肠道环境的细胞共培养模型,并对其应用于口服药物研发的体外评价吸收做出展望。
    Abstract: Cell co-culture system can better simulate the inner environment of human body, predict drug transport and metabolism in intestinal environment and increase the relation between in vitro cell model and integral animal test. In recent years, co-culture cell model plays an increasingly important role in evaluating the absorption of oral drugs, which becomes the highlight in the evaluation of drug oral absorption during new drug discovery. This essay summarized co-culture cell model which simulates intestinal environment and their application, and looked into the future of their application in evaluating oral drug intestinal absorption during oral drug discovery.
  • [1] Fröhlich E, Roblegg E. Models for oral uptake of nanoparticles in consumer products[J]. Toxicology, 2012,291(1-3):10-17.
    [2] Chen XM, Elisia I, Kitts DD. Defining conditions for the co-culture of Caco-2 and HT29-MTX cells using Taguchi design[J]. J Pharmacol Toxicol Meth, 2010, 61(3):334-342.
    [3] Behrens I, Stenberg P, Artursson P, et al. Transport of lipophilic drug molecules in a new mucus-secreting cell culture model based on HT29-MTX cells[J]. Pharm Res, 2001,18 (8):1138-1145.
    [4] Walter E, Janich S, Roessler BJ, et al. HT29-MTX/Caco-2 cocultures as an in vitro model for the intestinal epithelium: in vitro-in vivo correlation with permeability data from rats and humans[J]. J Pharm Sci,1996,85(10):1070-1076.
    [5] Woitiski CB, Sarmento B, Carvalho RA, et al. Facilitated nanoscale delivery of insulin across intestinal membrane models[J]. Int J Pharm, 2011, 412(1-2):123-131.
    [6] Rocha RA, Vélez D, Devesa V. In vitro evaluation of intestinal fluoride absorption using different cell models[J]. Toxicol Lett,2012,210(3):311-317.
    [7] Mahler GJ, Shuler ML, Glahn RP. Characterization of Caco-2 and HT29-MTX cocultures in an in vitro digestion/cell culture model used to predict iron bioavailability[J]. J Nutr Biochem, 2009, 20(7):494-502.
    [8] Vázquez M, Calatayud M, Vélez D, et al. Intestinal transport of methylmercury and inorganic mercury in various models of Caco-2 and HT29-MTX cells[J].Toxicology,2013,311(3):147-153.
    [9] Sam M, Linda F, David JB, et al. Melittin as a Permeability EnhancerⅡ: In vitro investigations in human mucus secreting intestinal monolayers and rat colonic mucosae [ J]. Pharm Res, 2007, 24(7): 1346-1356.
    [10] Maresca M, Mahfoud R, Garmy N, et al. The Mycotoxin deoxynivalenol affects nutrient absorption in human intestinal epithelial cells[J]. Amer Soc Nutr Sci,2002,132 (9):2723-2731.
    [11] Gagnon M, Zihler Berner A, Chervet N, et al. Comparison of the Caco-2, HT-29 and the mucus-secreting HT29-MTX intestinal cell models to investigate Salmonella adhesion and invasion[J].J Microbiol Meth,2013,94(3):274-279.
    [12] Lai YH, D'Souza MJ. Microparticle transport in the human intestinal M cell model[J]. J Drug Target, 2008, 16(1): 36-42.
    [13] Corr SC, Gahan CC, Hill C. M-cells: origin, morphology and role in mucosal immunity and microbial pathogenesis[J]. FEMS Immunol MedMicrobiol, 2008, 52(1): 2-12.
    [14] des Rieux A, Ragnarsson EG, Gullberg E, et al. Transport of nanoparticles across an in vitro model of the human intestinal follicle associated epithelium[J]. Eur J Pharm Sci, 2005,25(4-5): 455-465.
    [15] Gullberg E, Leonard M, Karlsson J, et al. Expression of specific markers and particle transport in a new human intestinal M-cell model[J]. Biochem Biophys Res Commun, 2000, 279(3): 808-813.
    [16] des Rieux A, Fievez V, Théate I, et al. An improved in vitro model of human intestinal follicle-associated epithelium to study nanoparticle transport by M cells[J]. Eur J Pharm Sci, 2007, 30(5): 380-391.
    [17] Garinot M, Fiévez V, Pourcelle V, et al. PEGylated PLGA-based nanoparticles targeting M cells for oral vaccination[J]. J Control Release, 2007, 120(3):195-204.
    [18] Pielage JF, Cichon C, Greune L, et al. Reversible differentiation of Caco-2 cells reveals galectin-9 as a surface marker molecule for human follicle-associated epithelia and M cell-like cells[J]. Int J Biochem Cell Biol, 2007, 39(10): 1886-1901.
    [19] Kadiyala I, Looa Y, Roy K, et al. Transport of chitosan-DNA nanoparticles in human intestinal M-cell model versus normal intestinal enterocytes[J]. Eur J Pharm Sci, 2010, 39(1-3):103-109.
    [20] Tonry JH, Popov SG, Narayanan A, et al. In vivo murine and in vitro M-like cell models of gastrointestinal anthrax[J]. Microb Infect, 2013, 15(1):37-44.
    [21] Antunes F, Andrade F, Araújo F, et al. Establishment of a triple co-culture in vitro cell models to study intestinal absorption of peptide drugs[J]. Eur J Pharm Biopharm, 2013, 83(3): 427-435.
    [22] Araújo F, Sarmento B.Towards the characterization of an in vitro triple co-culture intestine cell model for permeability studies[J].Int J Pharm, 2013, 458(1):128-134.
    [23] Han HK, Oh DM, Amidon GL. Cellular uptake mechanism of amino acid ester prodrugs in Caco-2/hPepT1 cells overexpressing a human peptide transporter[J]. Pharm Res,1998,15(9):1382-1386.
    [24] Annette B, Sibylle H, Kayoshi S, et al. Cell cultures as tools in biopharmacy[J]. Eur J Pharm Sci, 2000, 11 (Suppl2):S51-S60.
    [25] Tang F, Horie K, Borchardt RT. Are MDCK cells transfected with MRP2 gene a good model of the human intestinal mucosa?[J].Pharm Res, 2002, 19(6):773-779.
    [26] Cummins CL, Jacobsen W, Christians U, et al.CYP3A4-transfected Caco-2 cells as a tool for understanding biochemical absorption barriers: studies with sirolimus and midazolam[J]. J Pharmacol Exper Therap, 2004,308 (1):143-155.
    [27] Korjamo T, Monkkonen J, Uusitalo J, et al. Metabolic and efflux properties of Caco-2 cells stably transfected with nuclear receptors[J].Pharm Res, 2006, 23(9):1991-2001.
    [28] Agarwal S, Jain R, Pal D,et al. Functional characterization of peptide transporters in MDCKII-MDR1 cell line as a model for oral absorption studies[J]. Int J Pharm, 2007, 332(1-2):147-152.
    [29] Xiaokui H, Qi L, Changyuan W, et al. Enhancement effect of P-gp inhibitors on the intestinal absorption and antiproliferative activity of bestatin[J]. Eur J Pharm Sci, 2013, 50(3-4):420-428.
    [30] Hellinger E, Bakk ML, Pócza P,et al. Drug penetration model of vinblastine-treated Caco-2 cultures[J]. Eur J Pharmaceut Sci, 2010, 41(1): 96-106.
    [31] Brayden DJ, Griffin J. Avermectin transepithelial transport in MDR1- and MRP-transfected canine kidney monolayers[J].Vet Res Commun, 2008, 32(1):93-106.
    [32] Darwich AS, Neuhoff S, Jamei M, et al. Interplay of metabolism and transport in determining oral drug absorption and gut wall metabolism: a simulation assessment using the "advanced dissolution, absorption, metabolism (ADAM)" model[J]. Curr Drug Metabol,2010,11(9):716-729.
    [33] Schmohl M, Schneiderhan-Marra N, Baur N, et al. Characterization of immunologically active drugs in a novel organotypic co-culture model of the human gut and whole blood[J]. Int Immunopharmacol, 2012, 14(4):722-728.
    [34] Clayburgh DR, Shen L, Turner JR. A porous defense: the leaky epithelial barrier in intestinal disease[J]. Lab Invest, 2004, 84(3),282-291.
    [35] Yasuda M, Furuyashiki T, Nakamura T,et al. Immunomodulatory activity of enzymatically synthesized glycogen and its digested metabolite in a co-culture system consisting of differentiated Caco-2 cells and RAW264.7 macrophages[J].Food Funct, 2013,4(9), 1387-1393.
    [36] Leonard F, Collnot EM, Lehr CM. A three-dimensional coculture of enterocytes, monocytes and dendritic cells to model inflamed intestinal mucosa in vitro[J]. Mol Pharm, 2013, 7(6), 2103-2119.
    [37] 陈晓清,焦 红,程树军,等.Caco-2细胞与肠道菌共培养初建体外肠道共生模型[J].中山大学学报(医学科学版),2012,33(1):121-126.
    [38] Le Hégarat L, Huet S, Fessard V. A co-culture system of human intestinal Caco-2 cells and lymphoblastoid TK6 cells for investigating the genotoxicity of oral compounds[J]. Mutagenesis,2012,27(6):631-636.
  • [1] 陈兰, 何晓莉, 游飘雪, 王辉, 洪战英.  基于微流控芯片的体外肠道吸收模型构建及其应用进展 . 药学实践与服务, 2024, 42(2): 43-49, 59. doi: 10.12206/j.issn.2097-2024.202305003
    [2] 程俊飞, 赵安鹏, 赵以览, 王子晗, 李文斌, 王荣.  高原低氧环境影响胃肠道功能的因素及药物保护作用研究进展 . 药学实践与服务, 2023, 41(11): 648-653. doi: 10.12206/j.issn.2097-2024.202111018
    [3] 何晓莉, 施艺玮, 王辉, 戴建英, 洪战英.  细胞代谢组学及其在中枢神经系统疾病研究的应用进展 . 药学实践与服务, 2023, 41(2): 63-69. doi: 10.12206/j.issn.2097-2024.202203006
    [4] 胡北, 史英, 张朝绅, 许子华.  美沙拉嗪肠溶缓释颗粒剂的大鼠药动学及胃肠道分布研究 . 药学实践与服务, 2021, 39(4): 352-358. doi: 10.12206/j.issn.1006-0111.202007101
    [5] 刘昕竹, 徐人杰, 冯城, 魏昕.  红景天苷单体与坤复康片大鼠口服药动学特征的比较 . 药学实践与服务, 2021, 39(1): 49-52. doi: 10.12206/j.issn.1006-0111.202006043
    [6] 钱俞君, 秦春霞, 孙莉莉, 丁华敏, 李铁军.  建立以HIF-1α为靶标的高通量筛选防治动脉粥样硬化先导化合物的细胞模型 . 药学实践与服务, 2019, 37(1): 27-31. doi: 10.3969/j.issn.1006-0111.2019.01.007
    [7] 高越, 刘照元, 樊丽, 董国强, 周正, 罗云根, 张红武.  美国药师培养体系的启示 . 药学实践与服务, 2016, 34(3): 232-236. doi: 10.3969/j.issn.1006-0111.2016.03.010
    [8] 管文婕, 吴新安, 陈延杰.  玉屏风胶囊致急性胃肠道反应1例 . 药学实践与服务, 2015, 33(6): 576-576. doi: 10.3969/j.issn.1006-0111.2015.06.027
    [9] 吴佩芝, 胡丽辉, 刘丽娟, 翁少敏.  全自动口服药品摆药机的故障分析及处理方法 . 药学实践与服务, 2013, 31(1): 69-71. doi: 10.3969/j.issn.1006-0111.2013.01.021
    [10] 姚联珠.  铝碳酸镁预防阿奇霉素致小儿胃肠道反应效果观察 . 药学实践与服务, 2009, 27(2): 122-122,136.
    [11] 劳国琴, 赵卫国.  讨论老年住院患者口服药实行单剂量配方制的必要性 . 药学实践与服务, 2007, (6): 419-420.
    [12] 陈洪明, 郭澄.  外科胃肠道手术病人的营养支持 . 药学实践与服务, 2006, (2): 95-98.
    [13] 包志淑, 王陈翔.  浅谈西药口服药服药的时间和方法 . 药学实践与服务, 2004, (6): 345-348.
    [14] 方思永.  我院儿科处方中口服药浪费情况调查 . 药学实践与服务, 2002, (2): 118-119.
    [15] 蔡琳.  静滴ATP致急性胃肠道反应2例报告 . 药学实践与服务, 1999, (5): 278-278.
    [16] 郭涛.  非胃肠道营养剂中沉淀物的危害性 . 药学实践与服务, 1995, (3): 172-173.
    [17] 董雅珍, 孔保圻, 江佛湖, 杨秋英, 唐艰音.  吗丁啉对糖尿病患者胃肠道症状的疗效观察——附27例乳糖氢气呼吸试验 . 药学实践与服务, 1993, (1): 6-7.
    [18] LindaBeeley.  药源性胃肠道疾病 . 药学实践与服务, 1990, (3): 33-36.
    [19] HeinrichKoch.  口服抗菌新药——氟哌酸 . 药学实践与服务, 1985, (3): 10-11.
    [20] D.Piper, 苏开仲, 张紫洞.  阿司匹林与胃肠道疾病(连载之五) . 药学实践与服务, 1985, (1): 19-21.
  • 加载中
WeChat 点击查看大图
计量
  • 文章访问数:  2876
  • HTML全文浏览量:  216
  • PDF下载量:  715
  • 被引次数: 0
出版历程
  • 收稿日期:  2014-09-21
  • 修回日期:  2015-03-05

细胞共培养模型在口服药物吸收研究中的应用

doi: 10.3969/j.issn.1006-0111.2015.04.001
  • 中国医学科学院&北京协和医学院药用植物研究所, 北京 100193
    • 基金项目:  国家自然科学基金面上项目(81274094);协和研究生创新基金项目(10023-1007-1017)
  • 收稿日期: 2014-09-21
  • 修回日期: 2015-03-05

摘要: 细胞共培养体系能很好地模拟人体小肠生理环境,准确预测药物在肠道内的转运和代谢情况,增强体外细胞模型与整体动物实验研究之间的相关性,近年来在评价口服药物吸收方面发挥着越发重要的作用,已成为新药研发过程中评价药物口服吸收的热点。综述体外模拟肠道环境的细胞共培养模型,并对其应用于口服药物研发的体外评价吸收做出展望。

English Abstract

黎迎, 朱春燕. 细胞共培养模型在口服药物吸收研究中的应用[J]. 药学实践与服务, 2015, 33(4): 289-292,327. doi: 10.3969/j.issn.1006-0111.2015.04.001
引用本文: 黎迎, 朱春燕. 细胞共培养模型在口服药物吸收研究中的应用[J]. 药学实践与服务, 2015, 33(4): 289-292,327. doi: 10.3969/j.issn.1006-0111.2015.04.001
shu
LI Ying, ZHU Chunyan. Application of cell co-culture models in absorption of oral drug[J]. Journal of Pharmaceutical Practice and Service, 2015, 33(4): 289-292,327. doi: 10.3969/j.issn.1006-0111.2015.04.001
Citation: LI Ying, ZHU Chunyan. Application of cell co-culture models in absorption of oral drug[J]. Journal of Pharmaceutical Practice and Service, 2015, 33(4): 289-292,327. doi: 10.3969/j.issn.1006-0111.2015.04.001
shu

    全文HTML

参考文献 (38)

目录

    /

    返回文章
    返回

    版权所有：《药学实践与服务》编辑委员会

    主管、主办: 中国人民解放军海军军医大学地址: 上海市杨浦区国和路325号邮政编码: 200433

    电话: （021）81871324,81871397 E-mail: yxsjzzs@163.com

    网站备案号 沪ICP备05003363号-1

    本系统由 北京仁和汇智信息技术有限公司 开发    百度统计